Cannabis Patents For Pancreatic And Breast Cancers To Get A Review, CBIH Works On Treatment For Other Serious Conditions
Cannabis Patents For Pancreatic And Breast Cancers To Get A Review, CBIH Works On Treatment For Other Serious Conditions
Read Also: Study Discovers Medical Cannabis Drives 6x Improvement In Killing Breast Cancer CellsAs rates of pancreatic and breast cancer increase among the population, Cannabis Bioscience International Holdings (OTC:CBIH) is addressing the situation with new treatment methodologies. The Houston-based company submitted its inaugural pair of patents, targeting those with breast and pancreatic cancers for legal review and subsequent registration.
随着胰腺和乳腺癌的发病率在人口中的增加，Cannabis Bioscience International Holdings (OTC:CBIH)正在采用新的治疗方法来解决这一情况。位于休斯敦的该公司提交了首批专利，针对乳腺癌和胰腺癌进行法律审查和随后的注册。
Why It Matters
这为以下原因非常重要
These two cancers affect millions globally. Breast cancer impacts roughly one in eight women in the U.S. and pancreatic cancer is notorious for its late-stage diagnosis and grim prognosis, with a five-year survival rate below 10%.
这两种癌症影响着全球数百万人。乳腺癌影响着美国八分之一的妇女，而胰腺癌因其晚期诊断和可怕的预后而臭名昭著，五年存活率低于10%。
"Given the stark statistics associated with these cancers, our team recognizes the critical need for aggressive yet targeted interventions," said Jennifer Salguero, PhD in Science with emphasis on Microbiology. "We aim to not only target the tumors but also safeguard surrounding tissues, leveraging the inherent anti-tumor properties of cannabinoids."
“鉴于这些癌症所带来的严峻统计数据，我们的团队意识到积极而又有针对性的干预的重要性，”带有微生物学强调的博士Jennifer Salguero说道。 “我们的目标不仅是对肿瘤进行定点靶向治疗，还要利用大麻素固有的抗肿瘤特性，保护周围的组织。”
Read Also: Study Discovers Medical Cannabis Drives 6x Improvement In Killing Breast Cancer Cells
阅读更多: 研究发现医用大麻可导致消灭乳腺癌细胞的6倍改善
What's Next
接下来怎么做
CBIH said on Monday that it plans to "accelerate our pace of innovation... harnessing the antiviral, anti-inflammatory, and neuroprotective benefits of cannabinoids."
CBIH周一表示，计划“加快创新的步伐......利用大麻素的抗病毒、抗炎以及神经保护效果。”
How? The company said it would submit an additional 3 to 4 patents per month throughout the remainder of the year, with a focus on patents that could help those with herpes zoster, knee osteoarthritis and Alzheimer's disease.
该公司表示，将在今年余下的时间里每月提交3至4个专利申请，重点是可以帮助患有带状疱疹、膝骨关节炎和阿尔茨海默病的患者的专利申请。
The company will also boost its research team given its focus on patent and formulation development. CBIH welcomed an expert in biology, pharmaceutical chemistry, public health, and dermatic cosmetics, Sheila Tarqui, to its ranks.
鉴于专利和配方开发的重点，该公司还将加强研究团队。其中Sheila Tarqui是该公司专业领域（包括生物学、药剂化学、公共卫生和皮肤化妆品）的专家。
Additionally, the company is recruiting medical specialists in oncology and cardiology to develop other innovative treatments.
此外，该公司正在招聘肿瘤学和心脏病专家，以开发其他创新治疗方法。
"These strategies contribute to securing and protecting our intellectual property which is paramount. By harnessing cutting-edge therapies, artificial intelligence, and advanced biotechnological techniques, we aim to safeguard and successfully market our groundbreaking medical advancements," said Rosangel Andrades, research and development department director.
“这些策略有助于确保和保护我们的知识产权，这是至关重要的。通过利用尖端的治疗方法，人工智能和先进的生物技术手段，我们旨在保护并成功推广我们的突破性医疗进展，”研发部负责人Rosangel Andrades说。
Read Next
阅读下一篇
- Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
- 乳腺癌用大麻素和化疗：Psychedelics Biotech用户授权专利方法6100万美元
To learn more about innovation in cannabis, come join us at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.
了解更多有关大麻创新的信息，请于10月8日至9日前往芝加哥参加第19届Benzinga Cannabis Capital Conference。立即通过以下链接获取门票，以免价格飙升。